Cargando…
Somatic mutations in facial skin from countries of contrasting skin cancer risk
The incidence of keratinocyte cancer (basal cell and squamous cell carcinomas of the skin) is 17-fold lower in Singapore than the UK(1–3), despite Singapore receiving 2–3 times more ultraviolet (UV) radiation(4,5). Aging skin contains somatic mutant clones from which such cancers develop(6,7). We hy...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484783/ https://www.ncbi.nlm.nih.gov/pubmed/37537257 http://dx.doi.org/10.1038/s41588-023-01468-x |
_version_ | 1785102659079897088 |
---|---|
author | King, Charlotte Fowler, Joanna C. Abnizova, Irina Sood, Roshan K. Hall, Michael W. J. Szeverényi, Ildikó Tham, Muly Huang, Jingxiang Young, Stephanie Ming Hall, Benjamin A. Birgitte Lane, E. Jones, Philip H. |
author_facet | King, Charlotte Fowler, Joanna C. Abnizova, Irina Sood, Roshan K. Hall, Michael W. J. Szeverényi, Ildikó Tham, Muly Huang, Jingxiang Young, Stephanie Ming Hall, Benjamin A. Birgitte Lane, E. Jones, Philip H. |
author_sort | King, Charlotte |
collection | PubMed |
description | The incidence of keratinocyte cancer (basal cell and squamous cell carcinomas of the skin) is 17-fold lower in Singapore than the UK(1–3), despite Singapore receiving 2–3 times more ultraviolet (UV) radiation(4,5). Aging skin contains somatic mutant clones from which such cancers develop(6,7). We hypothesized that differences in keratinocyte cancer incidence may be reflected in the normal skin mutational landscape. Here we show that, compared to Singapore, aging facial skin from populations in the UK has a fourfold greater mutational burden, a predominant UV mutational signature, increased copy number aberrations and increased mutant TP53 selection. These features are shared by keratinocyte cancers from high-incidence and low-incidence populations(8–13). In Singaporean skin, most mutations result from cell-intrinsic processes; mutant NOTCH1 and NOTCH2 are more strongly selected than in the UK. Aging skin in a high-incidence country has multiple features convergent with cancer that are not found in a low-risk country. These differences may reflect germline variation in UV-protective genes. |
format | Online Article Text |
id | pubmed-10484783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104847832023-09-09 Somatic mutations in facial skin from countries of contrasting skin cancer risk King, Charlotte Fowler, Joanna C. Abnizova, Irina Sood, Roshan K. Hall, Michael W. J. Szeverényi, Ildikó Tham, Muly Huang, Jingxiang Young, Stephanie Ming Hall, Benjamin A. Birgitte Lane, E. Jones, Philip H. Nat Genet Letter The incidence of keratinocyte cancer (basal cell and squamous cell carcinomas of the skin) is 17-fold lower in Singapore than the UK(1–3), despite Singapore receiving 2–3 times more ultraviolet (UV) radiation(4,5). Aging skin contains somatic mutant clones from which such cancers develop(6,7). We hypothesized that differences in keratinocyte cancer incidence may be reflected in the normal skin mutational landscape. Here we show that, compared to Singapore, aging facial skin from populations in the UK has a fourfold greater mutational burden, a predominant UV mutational signature, increased copy number aberrations and increased mutant TP53 selection. These features are shared by keratinocyte cancers from high-incidence and low-incidence populations(8–13). In Singaporean skin, most mutations result from cell-intrinsic processes; mutant NOTCH1 and NOTCH2 are more strongly selected than in the UK. Aging skin in a high-incidence country has multiple features convergent with cancer that are not found in a low-risk country. These differences may reflect germline variation in UV-protective genes. Nature Publishing Group US 2023-08-03 2023 /pmc/articles/PMC10484783/ /pubmed/37537257 http://dx.doi.org/10.1038/s41588-023-01468-x Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter King, Charlotte Fowler, Joanna C. Abnizova, Irina Sood, Roshan K. Hall, Michael W. J. Szeverényi, Ildikó Tham, Muly Huang, Jingxiang Young, Stephanie Ming Hall, Benjamin A. Birgitte Lane, E. Jones, Philip H. Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title | Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title_full | Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title_fullStr | Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title_full_unstemmed | Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title_short | Somatic mutations in facial skin from countries of contrasting skin cancer risk |
title_sort | somatic mutations in facial skin from countries of contrasting skin cancer risk |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484783/ https://www.ncbi.nlm.nih.gov/pubmed/37537257 http://dx.doi.org/10.1038/s41588-023-01468-x |
work_keys_str_mv | AT kingcharlotte somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT fowlerjoannac somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT abnizovairina somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT soodroshank somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT hallmichaelwj somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT szeverenyiildiko somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT thammuly somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT huangjingxiang somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT youngstephanieming somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT hallbenjamina somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT birgittelanee somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk AT jonesphiliph somaticmutationsinfacialskinfromcountriesofcontrastingskincancerrisk |